Funding Opportunity |
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035
Funding Number: RFA CA 23 035
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 003
Funding Number: RFA CA 23 003
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) Apply for RFA CA 22 056
Funding Number: RFA CA 22 056
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional) Apply for RFA MH 22 130
Funding Number: RFA MH 22 130
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Apply for RFA DA 22 001
Funding Number: RFA DA 22 001
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 19 146
Funding Number: PAR 19 146
Agency: National Institutes of Health
Funding Amount: $200,000 |
International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) Apply for PA 18 773
Funding Number: PA 18 773
Agency: National Institutes of Health
Funding Amount: Case Dependent |
International Tobacco, and Health Research and Capacity Building Program (R01) Apply for RFA TW 16 003
Funding Number: RFA TW 16 003
Agency: National Institutes of Health
Funding Amount: $250,000 |
Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24) Apply for RFA CA 16 502
Funding Number: RFA CA 16 502
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $300,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) Apply for RFA CA 16 015
Funding Number: RFA CA 16 015
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $100,000 |
Cancer Target Discovery and Development Network (U01) Apply for RFA CA 16 014
Funding Number: RFA CA 16 014
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $750,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01) Apply for RFA AA 17 006
Funding Number: RFA AA 17 006
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01) Apply for PAR 16 338
Funding Number: PAR 16 338
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21) Apply for PAR 16 336
Funding Number: PAR 16 336
Agency: HHS-NIH11
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) Apply for PAR 16 337
Funding Number: PAR 16 337
Agency: HHS-NIH11
Funding Amount: $50,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) Apply for PAR 16 318
Funding Number: PAR 16 318
Agency: HHS-NIH11
Funding Amount: $200,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) Apply for PAR 16 317
Funding Number: PAR 16 317
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24) Apply for RFA AA 17 004
Funding Number: RFA AA 17 004
Agency: HHS-NIH11
Funding Amount: $350,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24) Apply for RFA AA 17 005
Funding Number: RFA AA 17 005
Agency: HHS-NIH11
Funding Amount: $600,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01) Apply for RFA AA 17 003
Funding Number: RFA AA 17 003
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33) Apply for PAR 16 291
Funding Number: PAR 16 291
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) Apply for PAR 16 292
Funding Number: PAR 16 292
Agency: HHS-NIH11
Funding Amount: $125,000 |
The NCI Transition Career Development Award (K22) Apply for PAR 16 293
Funding Number: PAR 16 293
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Silencing of HIV-1 Proviruses (R61/R33) Apply for RFA AI 16 038
Funding Number: RFA AI 16 038
Agency: HHS-NIH11
Funding Amount: $500,000 |
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Apply for PAR 16 284
Funding Number: PAR 16 284
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21) Apply for PAR 16 277
Funding Number: PAR 16 277
Agency: HHS-NIH11
Funding Amount: $200,000 |
Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) Apply for PAR 16 281
Funding Number: PAR 16 281
Agency: HHS-NIH11
Funding Amount: $28,000 |
Prescription Drug Abuse (R21) Apply for PA 16 232
Funding Number: PA 16 232
Agency: HHS-NIH11
Funding Amount: $200,000 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) Apply for PAR 16 278
Funding Number: PAR 16 278
Agency: HHS-NIH11
Funding Amount: $200,000 |
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) Apply for PAR 16 280
Funding Number: PAR 16 280
Agency: HHS-NIH11
Funding Amount: $92,000 |
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) Apply for PAR 16 279
Funding Number: PAR 16 279
Agency: HHS-NIH11
Funding Amount: $280,000 |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) Apply for PAR 16 276
Funding Number: PAR 16 276
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R01) Apply for PAR 16 275
Funding Number: PAR 16 275
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R21) Apply for PAR 16 274
Funding Number: PAR 16 274
Agency: HHS-NIH11
Funding Amount: $200,000 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01) Apply for PAR 16 266
Funding Number: PAR 16 266
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Methodology and Measurement in the Behavioral and Social Sciences (R21) Apply for PAR 16 261
Funding Number: PAR 16 261
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Apply for PA 16 258
Funding Number: PA 16 258
Agency: HHS-NIH11
Funding Amount: $200,000 |
Methodology and Measurement in the Behavioral and Social Sciences (R01) Apply for PAR 16 260
Funding Number: PAR 16 260
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R01) Apply for PAR 16 256
Funding Number: PAR 16 256
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R21) Apply for PAR 16 255
Funding Number: PAR 16 255
Agency: HHS-NIH11
Funding Amount: $200,000 |
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) Apply for PAR 16 257
Funding Number: PAR 16 257
Agency: HHS-NIH11
Funding Amount: $200,000 |
Building Evidence: Effective Palliative/End of Life Care Interventions (R01) Apply for PAR 16 250
Funding Number: PAR 16 250
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) Apply for PAR 16 234
Funding Number: PAR 16 234
Agency: HHS-NIH11
Funding Amount: $500,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21) Apply for PAR 16 248
Funding Number: PAR 16 248
Agency: HHS-NIH11
Funding Amount: $200,000 |
Gene Fusions in Pediatric Sarcomas (R21) Apply for PA 16 252
Funding Number: PA 16 252
Agency: HHS-NIH11
Funding Amount: $200,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01) Apply for PAR 16 249
Funding Number: PAR 16 249
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Gene Fusions in Pediatric Sarcomas (R01) Apply for PA 16 251
Funding Number: PA 16 251
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Prescription Drug Abuse (R01) Apply for PA 16 233
Funding Number: PA 16 233
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Neural Regulation of Cancer (R21) Apply for PAR 16 246
Funding Number: PAR 16 246
Agency: HHS-NIH11
Funding Amount: $200,000 |
Neural Regulation of Cancer (R01) Apply for PAR 16 245
Funding Number: PAR 16 245
Agency: HHS-NIH11
Funding Amount: Case Dependent |